These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27259817)

  • 1. Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms.
    Pantazopoulos H; Wiseman JT; Markota M; Ehrenfeld L; Berretta S
    Biol Psychiatry; 2017 Mar; 81(6):536-547. PubMed ID: 27259817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.
    Pantazopoulos H; Markota M; Jaquet F; Ghosh D; Wallin A; Santos A; Caterson B; Berretta S
    Transl Psychiatry; 2015 Jan; 5(1):e496. PubMed ID: 25603412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian modulation of anxiety: a role for somatostatin in the amygdala.
    Albrecht A; Thiere M; Bergado-Acosta JR; Poranzke J; Müller B; Stork O
    PLoS One; 2013; 8(12):e84668. PubMed ID: 24376834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Hormone Action in Somatostatin Neurons Regulates Anxiety and Fear Memory.
    Dos Santos WO; Juliano VAL; Chaves FM; Vieira HR; Frazao R; List EO; Kopchick JJ; Munhoz CD; Donato J
    J Neurosci; 2023 Oct; 43(40):6816-6829. PubMed ID: 37625855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
    Steullet P; Cabungcal JH; Bukhari SA; Ardelt MI; Pantazopoulos H; Hamati F; Salt TE; Cuenod M; Do KQ; Berretta S
    Mol Psychiatry; 2018 Oct; 23(10):2057-2065. PubMed ID: 29180672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.
    Gaspar P; Duyckaerts C; Febvret A; Benoit R; Beck B; Berger B
    Brain Res; 1989 Jun; 490(1):1-13. PubMed ID: 2569349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating patterns of amygdala-frontal functional connectivity in schizophrenia and bipolar disorder.
    Liu H; Tang Y; Womer F; Fan G; Lu T; Driesen N; Ren L; Wang Y; He Y; Blumberg HP; Xu K; Wang F
    Schizophr Bull; 2014 Mar; 40(2):469-77. PubMed ID: 23599250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in somatostatin-positive cell density in the amygdala of females with major depression.
    Douillard-Guilloux G; Lewis D; Seney ML; Sibille E
    Depress Anxiety; 2017 Jan; 34(1):68-78. PubMed ID: 27557481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in Schizophrenia.
    Dienel SJ; Dowling KF; Barile Z; Bazmi HH; Liu A; Vespoli JC; Fish KN; Lewis DA
    JAMA Psychiatry; 2023 Dec; 80(12):1235-1245. PubMed ID: 37647039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.
    Pantazopoulos H; Lange N; Baldessarini RJ; Berretta S
    Biol Psychiatry; 2007 Mar; 61(5):640-52. PubMed ID: 16950219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.
    Markota M; Sin J; Pantazopoulos H; Jonilionis R; Berretta S
    Schizophr Bull; 2014 Sep; 40(5):984-91. PubMed ID: 24936023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder.
    Girshkin L; O'Reilly N; Quidé Y; Teroganova N; Rowland JE; Schofield PR; Green MJ
    Psychoneuroendocrinology; 2016 May; 67():61-9. PubMed ID: 26874562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia.
    Berretta S; Pantazopoulos H; Lange N
    Biol Psychiatry; 2007 Oct; 62(8):884-93. PubMed ID: 17698040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia.
    Beal MF; Svendsen CN; Bird ED; Martin JB
    Neurochem Pathol; 1987 Jun; 6(3):169-76. PubMed ID: 2888067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
    Sibille E; Morris HM; Kota RS; Lewis DA
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):721-34. PubMed ID: 21226980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.
    Morris HM; Hashimoto T; Lewis DA
    Cereb Cortex; 2008 Jul; 18(7):1575-87. PubMed ID: 18203698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression.
    Guilloux JP; Douillard-Guilloux G; Kota R; Wang X; Gardier AM; Martinowich K; Tseng GC; Lewis DA; Sibille E
    Mol Psychiatry; 2012 Nov; 17(11):1130-42. PubMed ID: 21912391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of GABA, Somatostatin, and Corticotrophin-Releasing Hormone Expression in Axon Terminals That Target the Parabrachial Nucleus.
    Lundy R
    Chem Senses; 2020 May; 45(4):275-282. PubMed ID: 32107535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala.
    Rostkowski AB; Teppen TL; Peterson DA; Urban JH
    J Comp Neurol; 2009 Nov; 517(2):166-76. PubMed ID: 19731317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls.
    Tesli M; Skatun KC; Ousdal OT; Brown AA; Thoresen C; Agartz I; Melle I; Djurovic S; Jensen J; Andreassen OA
    PLoS One; 2013; 8(2):e56970. PubMed ID: 23437284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.